Table 3 Th17 and Treg numbers in 30... | American Society of Hematology

Table 3

Th17 and Treg numbers in 30 patients with and without pathologic digestive GVHD, according to conditioning regimen (second cohort)

	Acute GVHD MAC (n = 11)	Acute GVHD RIC (n = 10)	No GVHD (n = 9)
Th17,* median (range)	0 (0-1)	0 (0-2)	3 (2-7)
Treg,* median (range)	3 (1-7)	3.5 (2-6)	0 (0-1)
Th17/Treg,* median (range)	0.25 (0.14-0.50)	0.21 (0.10-0.50)	4.00 (3.00-10.00)
Th17/Treg < 1,† n (%)	11 (100)	10 (100)	0 (0)

	Acute GVHD MAC (n = 11)	Acute GVHD RIC (n = 10)	No GVHD (n = 9)
Th17,* median (range)	0 (0-1)	0 (0-2)	3 (2-7)
Treg,* median (range)	3 (1-7)	3.5 (2-6)	0 (0-1)
Th17/Treg,* median (range)	0.25 (0.14-0.50)	0.21 (0.10-0.50)	4.00 (3.00-10.00)
Th17/Treg < 1,† n (%)	11 (100)	10 (100)	0 (0)

MAC indicates myeloablative conditioning regimen; and RIC, reduced-intensity conditioning.

P < .001 for GVHD versus no GVHD after MAC and for GVHD versus no GVHD after RIC (by Mann-Whitney test).

P < .001 by Fisher exact test.